Tylenol autism lawsuit claims continue to evolve as families seek accountability for prenatal acetaminophen exposure. Thousands of parents allege that taking Tylenol or generic acetaminophen during pregnancy contributed to their children developing autism spectrum disorder or ADHD. The federal multidistrict litigation, known as MDL 3043, is currently on appeal before the Second Circuit Court of Appeals. As of May 2026, no settlements have been reached. However, new state-level actions and an FDA safety notice have kept this litigation alive and closely watched.
Case Timeline
Last checked: September 03, 2026
What Is the Tylenol Autism Lawsuit About?
| MDL Detail | Current Data |
|---|---|
| MDL Number | MDL-3043 |
| Pending Cases | 58 |
| Presiding Judge | Denise L. Cote |
| Federal District | NYS |
| Data Source | U.S. Judicial Panel on Multidistrict Litigation |
| Last Updated | August 03, 2026 |
The Tylenol autism lawsuit centers on acetaminophen, the most widely used pain reliever during pregnancy. Plaintiffs allege that manufacturers knew about studies linking prenatal acetaminophen use to neurodevelopmental disorders. Despite this evidence, they continued marketing the product as safe for pregnant women. The primary defendants include Johnson & Johnson, its consumer health spinoff Kenvue Inc., and major retailers such as Walmart, CVS, Costco, and Target that sold store-brand versions.
Multiple scientific studies have examined this potential link. Research from Johns Hopkins found that children with the highest cord-blood acetaminophen levels were roughly three times more likely to receive an ADHD or autism diagnosis. A 2025 Mount Sinai systematic review of 46 studies and over 100,000 participants found elevated risk ratios. However, a large 2024 JAMA study of nearly 2.5 million Swedish births found no association when using sibling controls. The science remains genuinely contested.
Children allegedly affected have been diagnosed with autism spectrum disorder, ADHD, or both. In most cases, their mothers used acetaminophen regularly during pregnancy for pain or fever management. The injuries claimed include developmental delays, behavioral challenges, and lifelong care needs.
MDL Case Status and Key Facts
| Detail | Information |
|---|---|
| MDL Number | 3043 |
| Full Title | In Re: Acetaminophen — ASD/ADHD Products Liability Litigation |
| Presiding Judge | Judge Denise L. Cote |
| Federal District | Southern District of New York |
| MDL Created | October 2022 |
| Peak Case Count | Approximately 500+ cases filed |
| Current Federal Status | All cases dismissed; appeal pending at Second Circuit |
| Oral Arguments | November 17, 2025 |
| Bellwether Trials | None scheduled — litigation never reached trial stage |
The Tylenol autism lawsuit hit a major turning point on December 18, 2023. Judge Cote issued a 148-page Daubert ruling excluding all five of the plaintiffs’ expert witnesses on general causation. She found that the experts had cherry-picked evidence and applied a “transdiagnostic analysis” not generally accepted in the scientific community. As a result, the court granted summary judgment on August 20, 2024 and dismissed all pending federal cases.
Plaintiffs appealed to the U.S. Court of Appeals for the Second Circuit. Oral arguments took place on November 17, 2025. Notably, two of the three judges questioned whether the lower court was too aggressive in excluding expert testimony. As of May 2026, the Second Circuit has not yet issued its decision. A reversal would reopen the MDL and move cases toward bellwether trials.
Who Qualifies for the Tylenol Autism Lawsuit?
You might be eligible for the Tylenol autism lawsuit if you used acetaminophen during pregnancy and your child was later diagnosed with autism or ADHD. Typically, plaintiffs must show they used Tylenol or generic acetaminophen products regularly during pregnancy. A formal diagnosis of autism spectrum disorder or ADHD from a qualified medical professional is generally required.
The exposure period covers any pregnancy during which the mother took acetaminophen-containing products. This includes brand-name Tylenol and store-brand equivalents. For example, Walmart’s Equate, CVS Health acetaminophen, and Costco’s Kirkland brand are all included. Evidence that may support a claim includes pharmacy records, medical charts noting acetaminophen use, and diagnostic records for the child.
Not everyone who took acetaminophen during pregnancy will qualify. Attorneys evaluating Tylenol autism lawsuit claims typically look for regular or sustained use rather than occasional doses. They also assess the child’s diagnosis, medical history, and other potential contributing factors. Consulting a licensed attorney is the best way to determine whether your specific situation meets the current filing criteria.
How to File a Tylenol Autism Lawsuit Claim
Filing a Tylenol autism lawsuit claim begins with contacting a mass tort attorney experienced in pharmaceutical litigation. Most firms offer free case evaluations. During this review, the attorney will assess your acetaminophen usage history and your child’s medical records. There is typically no upfront cost because these cases are handled on a contingency fee basis.
If your case is accepted, your attorney will prepare and file a complaint. For federal claims, this means filing in the Southern District of New York where MDL 3043 is consolidated. However, with the federal MDL currently on appeal, some attorneys are filing in state courts instead. You will likely need to complete a plaintiff fact sheet detailing your medical history, product usage, and your child’s diagnosis.
Statutes of limitations vary by state. In most cases, you have two to three years from the date of diagnosis or discovery of the potential link. However, some states have shorter deadlines. Acting promptly is important because missing the filing deadline could permanently bar your claim. An attorney licensed in your state can advise on the applicable time limits.
📨 Get Free Mass Tort Guides Alerts
Free · No spam · Unsubscribe anytime
Settlement Updates and What to Expect
As of May 2026, no settlements have been reached in the Tylenol autism lawsuit. Settlement negotiations cannot meaningfully proceed until the Second Circuit rules on the pending appeal. If the appellate court reverses Judge Cote’s Daubert ruling, expert testimony would be reinstated. That outcome would significantly increase settlement pressure on the defendants.
If the appeal succeeds, the litigation would likely move to bellwether trial selection. Bellwether trials test representative cases before a jury. Their outcomes typically influence global settlement discussions. Based on similar pharmaceutical MDLs, the timeline from bellwether selection to trial could take 12 to 18 months. Settlement values in mass tort cases involving childhood injuries vary widely depending on severity of diagnosis, strength of evidence, and duration of exposure.
Factors that may affect individual claim value include the severity of the child’s condition, documented proof of acetaminophen use during pregnancy, and the strength of the causal connection. Families should be prepared for a process that could take several years. In the meantime, the September 2025 FDA notice to physicians flagging a possible association between prenatal acetaminophen and autism has added regulatory weight to the plaintiffs’ position.
State-by-State Considerations
State tort reform laws can significantly affect Tylenol autism lawsuit outcomes. Each state has its own statute of limitations, damage caps, and rules for expert testimony. For example, Texas has seen major activity — Attorney General Ken Paxton sued Kenvue and Johnson & Johnson in October 2025 under the Texas Deceptive Trade Practices Act. In February 2026, a Texas judge denied the defendants’ motion to dismiss, allowing that case to proceed.
States with notable plaintiff activity include Texas, Pennsylvania, Florida, Illinois, and California. Some states apply stricter Daubert standards for expert testimony, while others use the more permissive Frye standard. State-level filings have become especially important while the federal MDL is paused on appeal. You can learn more about how your state’s laws may affect your claim by visiting our state-by-state tort reform guide.
Frequently Asked Questions
Is the Tylenol autism lawsuit still active in 2026?
Yes. While the federal MDL cases were dismissed, plaintiffs have appealed to the Second Circuit. Oral arguments were heard in November 2025. State court cases also remain active, particularly in Texas where the attorney general’s lawsuit is proceeding.
How long does a Tylenol autism lawsuit take to resolve?
Mass tort cases typically take several years from filing to resolution. The Tylenol autism lawsuit timeline depends heavily on the Second Circuit’s ruling. If the appeal succeeds, bellwether trials and settlement talks could follow within one to two years. Consulting a licensed attorney can provide a more specific estimate for your situation.
Can I still file a Tylenol autism lawsuit claim?
You may still be able to file depending on your state’s statute of limitations. Many states allow two to three years from the date you discovered or should have discovered the potential link. However, deadlines vary. Speaking with a mass tort attorney promptly is the best way to protect your rights and determine eligibility.
Check If You May Qualify
Mass tort eligibility depends on your specific exposure, injuries, and the state where you live. A licensed mass tort attorney can evaluate your situation at no upfront cost — most work on contingency, meaning you pay nothing unless you recover compensation.
Official Sources & Resources
For verified mass tort and MDL information:
- JPML: jpml.uscourts.gov — official MDL statistics and transfer orders
- DOJ: justice.gov — settlement announcements and press releases
- FDA: fda.gov — drug recalls, warning letters, and safety alerts
- CDC: cdc.gov — health condition data and exposure guidelines
- EPA: epa.gov — environmental contamination data
- Cornell LII: law.cornell.edu — plain-English legal definitions
Content last reviewed May 2026. This is general educational information, not legal advice. If you notice outdated information, please contact us.
Related Guides
- All Active MDL Cases
- More in This Category
- Tort Reform by State — 50-State Comparison
- All 50 State Tort Reform Guides
- Mass Tort Explainers
- Demographic Guides
- Mass Tort Tips
- Georgia Tort Reform Guide
- Texas Tort Reform Guide
- Ohio Tort Reform Guide
Attorney Advertising. The information on this page is provided for general informational purposes only and does not constitute legal advice. No attorney-client relationship is created by accessing or using this content. Every case is unique, and results depend on the specific facts and circumstances involved. Past settlement amounts and case outcomes do not guarantee similar results in your case. If you believe you have a legal claim, you should consult with a licensed attorney in your jurisdiction who can evaluate your specific situation.